rs2054780

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_018566.4(YOD1):​c.*753G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 152,600 control chromosomes in the GnomAD database, including 1,192 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1187 hom., cov: 32)
Exomes 𝑓: 0.12 ( 5 hom. )

Consequence

YOD1
NM_018566.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.30

Publications

13 publications found
Variant links:
Genes affected
YOD1 (HGNC:25035): (YOD1 deubiquitinase) Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. The protein encoded by this gene belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
PFKFB2 (HGNC:8873): (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2) The protein encoded by this gene is involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate, and a fructose-2,6-biphosphatase activity that catalyzes the degradation of fructose-2,6-bisphosphate. This protein regulates fructose-2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as a homodimer. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
YOD1NM_018566.4 linkc.*753G>A 3_prime_UTR_variant Exon 2 of 2 ENST00000315927.9 NP_061036.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
YOD1ENST00000315927.9 linkc.*753G>A 3_prime_UTR_variant Exon 2 of 2 1 NM_018566.4 ENSP00000326813.4

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18268
AN:
152050
Hom.:
1184
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.123
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.118
Gnomad EAS
AF:
0.0748
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.142
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.145
GnomAD4 exome
AF:
0.123
AC:
53
AN:
432
Hom.:
5
Cov.:
0
AF XY:
0.0984
AC XY:
25
AN XY:
254
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.128
AC:
53
AN:
414
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
12
Other (OTH)
AF:
0.00
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.120
AC:
18282
AN:
152168
Hom.:
1187
Cov.:
32
AF XY:
0.122
AC XY:
9107
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0703
AC:
2920
AN:
41524
American (AMR)
AF:
0.197
AC:
3009
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
409
AN:
3466
East Asian (EAS)
AF:
0.0748
AC:
388
AN:
5188
South Asian (SAS)
AF:
0.111
AC:
537
AN:
4820
European-Finnish (FIN)
AF:
0.142
AC:
1499
AN:
10580
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9066
AN:
67992
Other (OTH)
AF:
0.143
AC:
303
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
826
1652
2478
3304
4130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.133
Hom.:
2095
Bravo
AF:
0.122
Asia WGS
AF:
0.0920
AC:
318
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Benign
0.94
PhyloP100
2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2054780; hg19: chr1-207221612; API